9.20
price down icon4.45%   -0.43
 
loading

Finanzdaten der Regenxbio Inc-Aktie (RGNX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
29.67%
15.62
22.21 28.91 19.98 19.14
Cost Of Revenue
61.89%
4.283
11.24 12.39 9.475 4.112
Gross Profit
3.32%
11.34
10.97 16.53 10.50 15.03
Operating Expenses
0.43%
75.20
74.88 81.49 83.61 81.18
Interest Income/Expense
44.75%
1.973
1.363 1.624 1.12 2.755
Benefits Costs and Expenses
7.39%
78.95
85.25 90.78 92.04 85.81
Costs And Expenses
7.70%
79.48
86.12 93.87 93.08 85.30
Depreciation and Amortization
3.58%
4.18
4.335 4.372 4.435 4.178
Operating Income/Loss
0.06%
-63.86
-63.90 -64.96 -73.11 -66.16
Nonoperating Income/Loss
38.17%
0.533
0.862 3.092 1.047 -0.519
Income/Loss From Continuing Operations Before Tax
0.46%
-63.33
-63.04 -61.87 -72.06 -66.68
Income/Loss From Continuing Operations After Tax
0.70%
-63.33
-62.89 -61.87 -72.06 -66.68
Net Income/Loss
0.70%
-63.33
-62.89 -61.87 -72.06 -66.68
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4.68%
45.73
43.69 0.0439 0.0435 0.0435
Diluted Average Shares
4.68%
45.73
43.69 0.0439 0.0435 0.0435
Basic Earnings Per Share
2.82%
-1.38
-1.42 -1.41 -1.66 -1.53
Diluted Earnings Per Share
2.82%
-1.38
-1.42 -1.41 -1.66 -1.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):